MED23 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.774600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.503580E-01
Normal-vs-Stage2
3.961100E-04
Normal-vs-Stage3
8.891900E-02
Normal-vs-Stage4
8.499500E-02
Stage1-vs-Stage2
3.437600E-01
Stage1-vs-Stage3
1.005180E-01
Stage1-vs-Stage4
8.049000E-01
Stage2-vs-Stage3
3.021100E-03
Stage2-vs-Stage4
6.974000E-01
Stage3-vs-Stage4
4.195900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.792200E-04
Normal-vs-AfricanAmerican
1.899440E-01
Normal-vs-Asian
5.162200E-02
Caucasian-vs-AfricanAmerican
6.249800E-01
Caucasian-vs-Asian
8.383200E-01
AfricanAmerican-vs-Asian
7.673200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.621600E-04
Normal-vs-Female
5.059700E-03
Male-vs-Female
1.095440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.657030E-01
Normal-vs-Age(41-60Yrs)
3.556400E-03
Normal-vs-Age(61-80Yrs)
8.246700E-04
Normal-vs-Age(81-100Yrs)
1.707550E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.501800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.540600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.212600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.352000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.825200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.482200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.720800E-03
Normal-vs-Daily Drinker
6.240000E-04
Normal-vs-Weekly Drinker
1.861650E-03
Normal-vs-Occasional Drinker
1.975920E-02
Normal-vs-Social Drinker
2.099900E-02
Non Drinker-vs-Daily Drinker
1.642590E-01
Non Drinker-vs-Weekly Drinker
4.219200E-01
Non Drinker-vs-Occasional Drinker
7.193400E-01
Non Drinker-vs-Social Drinker
5.382600E-01
Daily Drinker-vs-Weekly Drinker
6.577400E-01
Daily Drinker-vs-Occasional Drinker
1.410410E-01
Daily Drinker-vs-Social Drinker
8.588400E-02
Weekly Drinker-vs-Occasional Drinker
3.339200E-01
Weekly Drinker-vs-Social Drinker
2.201000E-01
Occasional Drinker-vs-Social Drinker
8.301800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.169900E-02
Normal-vs-Grade 2
1.560100E-02
Normal-vs-Grade 3
1.998360E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.561800E-02
Grade 1-vs-Grade 3
1.750810E-01
Grade 1-vs-Grade 4
4.169900E-02
Grade 2-vs-Grade 3
6.597000E-01
Grade 2-vs-Grade 4
1.560100E-02
Grade 3-vs-Grade 4
1.998360E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.388430E-04
Normal-vs-NonDiabetic
4.590800E-04
Diabetic-vs-NonDiabetic
1.698620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.585600E-04
Normal-vs-NoPancreatitis
3.621000E-04
Pancreatitis-vs-NoPancreatitis
1.006420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.753970E-02
Normal-vs-N1
1.620280E-04
N0-vs-N1
1.942150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.911200E-01
Normal-vs-TP53-NonMutant
4.979900E-02
TP53-Mutant-vs-TP53-NonMutant
1.622820E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
